HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$0.95
Day range
$0.95 - $0.95
Year range
$0.91 - $1.70
Market cap
3.07M USD
Avg Volume
31.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.81M | 17.65% |
Net income | -3.78M | -22.94% |
Net profit margin | — | — |
Earnings per share | -1.17 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.34M | -77.58% |
Total assets | 4.70M | -63.98% |
Total liabilities | 1.84M | 42.60% |
Total equity | 2.86M | — |
Shares outstanding | 3.28M | — |
Price to book | 1.09 | — |
Return on assets | -161.06% | — |
Return on capital | -202.03% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.78M | -22.94% |
Cash from operations | -2.57M | 1.12% |
Cash from investing | 500.00K | -81.76% |
Cash from financing | 57.00K | 78.12% |
Net change in cash | -2.02M | -1,247.16% |
Free cash flow | -1.20M | 15.49% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
6
